Genetic Analysis (GEAN) | Spotlight

Home

Genetic Analysis is active in medical technology. The company conducts research and development in the field of diagnostics, with the greatest focus on the human microbiome. The technology is based on the company's research platform and the products are used, for example, for testing and analysis of bacteria and other viruses. The largest operations are in the Nordic market.

Quotes for Genetic Analysis AS

Right Now

+/-: -0.6
%: -6,82%
Latest: 8.2
High: 8.78
Low: 7.88
Volume: 230 062
Turnover (NOK): 1 871 725
Value (MNOK): 204,3

Board

CEO

Ronny Hermansen

Chairperson of the Board

Kathryn Baker

Board

Ashok Shah
Camilla Huse Bondesson
Rune Sørum
Staffan Strömberg

News

2021-11-09 10:00:00 Interim report January – September 2021
2021-10-28 13:02:08 Genetic Analysis awarded important US patent covering a companion diagnostic method for optimising IBS interventions
2021-10-19 08:43:50 Genetic Analysis enters a Service Agreement with Eurofins ADME BIOANALYSES – The first CRO to offer the GA-map® Microbiome test
2021-10-14 08:46:22 Genetic Analysis receives important patent allowance in China
2021-10-05 14:51:25 Microbiome Dx Genetic Analysis raises USD 6.8 M in IPO

Show More

News agencies

2021-11-09 10:27:42 Direkt: RESULTATET SJÖNK TILL -6,8 MLN NOK 3 KV
2021-11-09 10:24:04 Finwire: Genetic Analysis minskar nettoresultat men har säkrat viktiga patent under tredje kvartalet
2021-10-28 13:20:37 Finwire: Genetic Analysis erhåller viktigt patent i USA
2021-10-19 08:58:34 Finwire: Genetic Analysis ingår serviceavtal med kontraktsforskningsorganisation
2021-10-14 09:04:34 Finwire: Genetic Analysis erhåller patent i Kina

Show More

Upcoming reports

2022-02-18 Bokslutskommuniké 2021

Annual reports, prospectus etc.